PubMed latest
Current biomedical literature searches for peptide research terms, sorted by date when the source supports it.
Open PubMed radarA live peptide research directory for mechanisms, clinical evidence, safety constraints, regulatory context, and source-level literature navigation across 62 evidence-graded monographs.
Search by peptide name, synonym, mechanism, clinical domain, route, or evidence status. The directory is data-driven so new peptide pages can be added by extending the page list rather than rebuilding the interface.
Free browser tools built alongside the directory — reconstitution and dosing math, side-by-side comparison, and a plain-language glossary. Educational only, never a substitute for clinical judgment.
Vial strength + bacteriostatic water + target dose → concentration, draw volume, insulin-syringe units, and doses per vial, with a live syringe diagram.
Line up two or three peptides by class, regulatory status, and research summary, then jump to any full monograph.
Plain-language definitions of the dosing, mechanism, pharmacology, and regulatory terms used across ATLAS.
These links open current source searches at PubMed, ClinicalTrials.gov, FDA, and WADA so visitors can move from ATLAS summaries into live literature, trial, regulatory, and safety material.
Current biomedical literature searches for peptide research terms, sorted by date when the source supports it.
Open PubMed radarActive and completed human studies for peptides, incretins, GHRH analogs, regenerative agents, and neuropeptides.
Open trial radarRegulatory context for approved products, compounding review, safety communications, and availability changes.
Open FDA searchWADA status matters for athletes and clinicians managing prohibited or investigational peptide exposure.
Open WADA listThese topic routes connect common peptide research questions to live source material: mechanisms, safety alerts, trial updates, comparisons, dosing context, and translational evidence.
Submit qualified user information for clinical-layer review, including protocol architecture, monitoring overlays, contraindication matrices, and implementation notes as future access layers are released.
The homepage is built around repeatable taxonomy: molecule class, clinical domain, evidence state, regulatory status, and research route. New monographs can join the directory without changing the core navigation model.